Stephen Joseph Pakola

Title: The Innovations of Stephen Joseph Pakola

Introduction

Stephen Joseph Pakola is an accomplished inventor based in Irvington, NY (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of rare genetic disorders. His work focuses on innovative methods to deliver therapeutic agents to patients in need.

Latest Patents

Stephen Pakola holds a patent for the treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS). This patent describes compositions and methods for delivering recombinant human iduronate-2-sulfatase produced by human neuronal or glial cells to the cerebrospinal fluid of the central nervous system (CNS) of individuals diagnosed with mucopolysaccharidosis II (MPS II). He has 1 patent to his name.

Career Highlights

Pakola is currently associated with Regenxbio Inc., a company known for its innovative gene therapy solutions. His work at Regenxbio has positioned him as a key player in the development of treatments for genetic disorders.

Collaborations

Some of his notable coworkers include Paulo Falabella and Marie-Laure Nevoret. Their collaborative efforts contribute to the advancement of research and development in the field of biotechnology.

Conclusion

Stephen Joseph Pakola's innovative work in the treatment of mucopolysaccharidosis II showcases his dedication to improving patient outcomes through biotechnology. His contributions are paving the way for future advancements in the field.